Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
CSF proteomics
Description:
The large-scale analysis of proteins in cerebrospinal fluid, used to investigate neurological disease mechanisms and discover biomarkers.
Related topics:
Alzheimer's disease research and treatments (17%),
Advanced Proteomics Techniques and Applications (14%),
Dementia and Cognitive Impairment Research (13%)
OpenAlex ID:
keywords/csf-proteomics
CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases
2008
·
Jing Zhang
, Izabela Sokal
, et al.
·
American Journal of Clinical Pathology
·
288
Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid
2020
·
Johan Virhammar
, Eva Kumlien
, et al.
·
Neurology
·
257
PDF
CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice
2019
·
Renzo Mancuso
, Gemma Fryatt
, et al.
·
Brain
·
239
PDF
The cerebrospinal fluid: regulator of neurogenesis, behavior, and beyond
2012
·
Mauro W. Zappaterra
, Maria K. Lehtinen
·
Cellular and Molecular Life Sciences
·
208
CSF biomarkers for Alzheimer’s disease: use in early diagnosis and evaluation of drug treatment
2005
·
Kaj Blennow
·
Expert Review of Molecular Diagnostics
·
141
Proteomics analysis of human cerebrospinal fluid
2004
·
Xianglin Yuan
, Dominic M. Desiderio
·
Journal of Chromatography B
·
126
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers
2008
·
Stéphane Roche
, Audrey Gabelle
, et al.
·
PROTEOMICS - CLINICAL APPLICATIONS
·
106
PDF
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics—Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease
2014
·
Mikko Hölttä
, Lennart Minthon
, et al.
·
Journal of Proteome Research
·
102
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
2022
·
Pieter Jelle Visser
, Lianne M. Reus
, et al.
·
Molecular Neurodegeneration
·
100
PDF
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
2020
·
Maotian Zhou
, Rafi U. Haque
, et al.
·
Clinical Proteomics
·
99
PDF
MALDI-TOF Mass Spectrometry Analysis of Cerebrospinal Fluid Tryptic Peptide Profiles to Diagnose Leptomeningeal Metastases in Patients with Breast Cancer
2005
·
Lennard J. Dekker
, Willem Boogerd
, et al.
·
Molecular & Cellular Proteomics
·
90
PDF
Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
2010
·
Karin D. van Dijk
, Charlotte E. Teunissen
, et al.
·
Neurobiology of Disease
·
78
PDF
Proteomics of human cerebrospinal fluid – the good, the bad, and the ugly
2007
·
Jing Zhang
·
PROTEOMICS - CLINICAL APPLICATIONS
·
67
Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease
2013
·
Liang-Hao Guo
, Panagiotis Alexopoulos
, et al.
·
European Archives of Psychiatry and Clinical Neuroscience
·
64
Biochemical Markers in CSF of ALS Patients
2008
·
Sigurd Sussmuth
, Johannes Brettschneider
, et al.
·
Current Medicinal Chemistry
·
62
Molecular‐based diagnosis of multiple sclerosis and its progressive stage
2017
·
Christopher Barbour
, Peter Kosa
, et al.
·
Annals of Neurology
·
60
Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis
2021
·
Sergio Muñiz-Castrillo
, Julien Jacques Hedou
, et al.
·
Brain
·
58
PDF
Early Discriminatory Diagnosis of Dementia with Lewy Bodies
2008
·
Dag Aarsland
, Martin Kurz
, et al.
·
Dementia and Geriatric Cognitive Disorders
·
54
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
2023
·
Yanaika S. Hok-A-Hin
, Marta del Campo
, et al.
·
Journal of Neuroinflammation
·
43
PDF
Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application
2024
·
Nicholas Mikolajewicz
, Patricia P. Yee
, et al.
·
Journal of Clinical Oncology
·
42
PDF
Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: Candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease
2008
·
Sang Min Jung
, KiBeom Lee
, et al.
·
Neuroscience Letters
·
42
Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies
2017
·
MHD Rami Al Shweiki
, Patrick Oeckl
, et al.
·
Expert Review of Proteomics
·
37
The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma
2015
·
M.C. Mabray
, R.F. Barajas
, et al.
·
American Journal of Neuroradiology
·
37
PDF
Discovery of novel CSF biomarkers to predict progression in dementia using machine learning
2023
·
Dea Gogishvili
, Ellen Vromen
, et al.
·
Scientific Reports
·
35
PDF
CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
2021
·
Manuel Comabella
, Jaume Sastre-Garriga
, et al.
·
Neurology Neuroimmunology & Neuroinflammation
·
35
PDF
Show more works
View as search
Works count:
162
Citation count:
3,104
Year
Topic
Type